IP Infusion Announces Innovative Tunneling Technologies for Coexisting IPv4 and IPv6 Networks

SUNNYVALE, Calif., March 9 /PRNewswire/ -- IP Infusion, an ACCESS company and provider of intelligent software for Next Generation Network (NGN) equipment manufacturers and converged IP service providers, today announced innovative tunneling technologies that enable the coexistence of IPv4 and IPv6 networks. Since its inception in 1999, IP Infusion has pioneered the development of solutions for IPv4 and IPv6 technologies, and has carried out extensive testing with Japanese carriers. IP Infusion is making its solution available immediately for operators and Internet service providers as ZebOS® Rapid Deployment.

The IPv6 protocol was developed to support the growing need for additional IP addresses brought about by the decreasing availability of address space for 32 bit for IPv4. Due to the worldwide growth of the Internet and the increasing use of information appliances, especially in ASEAN countries, available IPv4 addresses are expected to run out in the very near future. IPv6 addressing provides an important solution as an alternative to IPv4, and has brought about the diversification of IP address environments. Operators urgently need not only to introduce IPv6 addresses, but also to manage their networks in mixed IPv4 and IPv6 environments.

The telecommunications industry has been exploring a variety of solutions, such as network address sharing technologies and network translation technologies. The comprehensive tunneling technologies for coexisting IPv4 and IPv6 networks developed by IP Infusion offer an immediate solution for operators.

IPv6 over IPv4 Tunneling Solution

IP Infusion's ZebOS Rapid Deployment forwards IPv6 traffic though IPv4 networks and is based on 6rd (IPv6 rapid deployment) specifications which are published as a Request for Comments (RFC) by the Internet Engineering Task Force (IETF). The proposed IETF 6rd solution utilizes stateless IPv6 in IPv4 encapsulation in order to transit IPv4-only network infrastructure, and can achieve high scalability by leveraging stateless tunneling technology. IP Infusion's ZebOS Rapid Deployment also provides an accounting function which manages user traffic for enabling Internet services, and a filtering function which differentiates users -- both important functions in order for carriers to deploy a new IPv6 service by using 6rd.

BBIX Inc. currently provides an Internet exchange service in Japan and plans to launch an IPv6 roaming service for other Internet service providers based on IP Infusion's ZebOS Rapid Deployment.

"We intend to be a leader in IPv6 transition by leveraging IP Infusion's ZebOS Rapid Deployment solution," said Keiichi Makizono, Director of the board for BBIX Inc. "IP Infusion is one of the most important partners for BBIX in driving IPv6 adoption."

"With the growing number of worldwide providers adopting IPv6, support for this routing protocol in Next Generation Metro Networks is a must," said Koichi Narasaki, president and CEO of IP Infusion. "As networks transition to IPv6, legacy support for IPv4 is imperative. IP Infusion's revolutionary ZebOS Rapid Deployment solution enables this transition for network providers."

About ACCESS

ACCESS CO., LTD. is a global company providing leading technology, software products and platforms for Web browsing, mobile phones, wireless handhelds, digital TVs and other networked devices. ACCESS' product portfolio, including its NetFront™ Browser, ACCESS Linux Platform™ and Garnet™ OS, provides customers with solutions that enable faster time to market, flexibility and customizability. The company, headquartered in Tokyo, Japan, operates subsidiaries and affiliates in Asia, Europe and the United States. ACCESS is listed on the Tokyo Stock Exchange Mother's Index under the number 4813. For more information about ACCESS, please visit http://www.access-company.com/.

About IP Infusion

IP Infusion Inc. delivers advanced software solutions that power communications equipment for packet-based Next Generation Networks (NGN). With a unique modular architecture and the industry's broadest suite of communication protocols, IP Infusion enhances product differentiation and market agility for many of the world's leading network equipment vendors. Incorporated in Delaware in October 1999, IP Infusion is headquartered in Sunnyvale, California, and is a wholly owned and independently-operated subsidiary of ACCESS Systems Americas, Inc., a wholly owned U.S. subsidiary of ACCESS CO., LTD., of Tokyo, Japan. For more information about IP Infusion, please visit www.ipinfusion.com.

© 2010 ACCESS CO., LTD. All rights reserved.

ACCESS, the ACCESS logo, NetFront, ACCESS Linux Platform and Garnet are registered trademarks or trademarks of ACCESS CO., LTD. in the United States, Japan and/or other countries.

IP Infusion and ZebOS are either registered trademarks or trademarks of IP Infusion Inc. in the United States and/or other countries.

The registered trademark LINUX® is used pursuant to a sublicense from Linux Mark Institute, the exclusive licensee of Linus Torvalds, owner of the mark on a world-wide basis.

All other trademarks, logos and trade names mentioned in the document are the property of their respective owners.

SOURCE IP Infusion Inc.